Cite
HARVARD Citation
Yamamoto, T. et al. (2022). Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study. Nutrition and cancer. pp. 3118-3127. [Online].